News

FDA vaccine chief leaving agency after less than 3 months
The Food and Drug Administration’s polarizing vaccine chief is leaving the agency after a brief tenure that drew the ire of ...
US FDA declines to approve Regeneron's blood cancer therapy for second time
Regeneron said on Friday the U.S. Food and Drug Administration has once again declined to approve its blood cancer therapy, ...
STAT21h
FDA to stress opioids’ risk of overdose, death in new medication safety labels
The FDA will soon require prescription opioid manufacturers to include stronger language on the medications’ labels warning ...
FDA's top vaccine official leaves agency after controversial decisions
Dr. Vinay Prasad, an oncologist who was a fierce critic of COVID vaccine and mask mandates, was appointed in May.
Fierce Pharma2d
FDA taps newly appointed George Tidmarsh as acting CBER leader after Vinay Prasad exit
Freshly appointed Center for Drug Evaluation and Research (CDER) leader George Tidmarsh, M.D., Ph.D., will now take on the role of acting director of CBER as well, according to an internal letter from ...
STAT2d
FDA names drug regulator Tidmarsh acting head of biologics center after Prasad’s exit
George Tidmarsh is taking on more responsibilities at FDA after the sudden departure of top official Vinay Prasad.
Healio1d
FDA approves vagus nerve stimulator for rheumatoid arthritis
The FDA has approved the SetPoint System, a vagus nerve stimulator from SetPoint Medical, for the treatment of rheumatoid ...
WLRN12h
Miami-based healthcare company receives new FDA approval of Parkinson’s treatment
Insightec, the Miami-based innovator in focused ultrasound to transform patient care, announced July 8 the U.S. Food and Drug ...